BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12853388)

  • 1. C-terminal region of outer surface protein C binds borreliacidal antibodies in sera from patients with Lyme disease.
    Jobe DA; Lovrich SD; Schell RF; Callister SM
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):573-8. PubMed ID: 12853388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.
    Lovrich SD; Jobe DA; Schell RF; Callister SM
    Clin Diagn Lab Immunol; 2005 Jun; 12(6):746-51. PubMed ID: 15939749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significantly improved accuracy of diagnosis of early Lyme disease by peptide enzyme-linked immunosorbent assay based on the borreliacidal antibody epitope of Borrelia burgdorferi OspC.
    Jobe DA; Lovrich SD; Asp KE; Mathiason MA; Albrecht SE; Schell RF; Callister SM
    Clin Vaccine Immunol; 2008 Jun; 15(6):981-5. PubMed ID: 18417666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific immune response to a synthetic peptide derived from outer surface protein C of Borrelia burgdorferi predicts protective borreliacidal antibodies.
    Ikushima M; Matsui K; Yamada F; Kawahashi S; Nishikawa SK
    FEMS Immunol Med Microbiol; 2000 Sep; 29(1):15-21. PubMed ID: 10967255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Borreliacidal antibody production against outer surface protein C of Borrelia burgdorferi.
    Rousselle JC; Callister SM; Schell RF; Lovrich SD; Jobe DA; Marks JA; Wieneke CA
    J Infect Dis; 1998 Sep; 178(3):733-41. PubMed ID: 9728542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Borreliacidal activity of early Lyme disease sera against complement-resistant Borrelia afzelii FEM1 wild-type and an OspC-lacking FEM1 variant.
    Kraiczy P; Hunfeld KP; Peters S; Würzner R; Acker G; Wilske B; Brade V
    J Med Microbiol; 2000 Oct; 49(10):917-928. PubMed ID: 11023189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Borreliacidal OspC antibody response of canines with Lyme disease differs significantly from that of humans with Lyme disease.
    Lovrich SD; La Fleur RL; Jobe DA; Johnson JC; Asp KE; Schell RF; Callister SM
    Clin Vaccine Immunol; 2007 May; 14(5):635-7. PubMed ID: 17344346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent Anti-
    Markowicz M; Reiter M; Gamper J; Stanek G; Stockinger H
    Microbiol Spectr; 2021 Dec; 9(3):e0102021. PubMed ID: 34937165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a unique borreliacidal epitope on the outer surface protein C of Borrelia burgdorferi.
    Yang X; Li Y; Dunn JJ; Luft BJ
    FEMS Immunol Med Microbiol; 2006 Oct; 48(1):64-74. PubMed ID: 16965353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant OspC from Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii in the serodiagnosis of Lyme borreliosis.
    Panelius J; Lahdenne P; Heikkilä T; Peltomaa M; Oksi J; Seppälä I
    J Med Microbiol; 2002 Sep; 51(9):731-739. PubMed ID: 12358063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of B-cell epitopes of Borrelia burgdorferi outer surface protein C by screening a phage-displayed gene fragment library.
    Pulzova L; Flachbartova Z; Bencurova E; Potocnakova L; Comor L; Schreterova E; Bhide M
    Microbiol Immunol; 2016 Oct; 60(10):669-677. PubMed ID: 27619624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody response to OspC-I synthetic peptide derived from outer surface protein C of Borrelia burgdorferi in sera from Japanese forestry workers.
    Ikushima M; Yamada F; Kawahashi S; Okuyama Y; Matsui K
    Epidemiol Infect; 1999 Jun; 122(3):429-33. PubMed ID: 10459646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved Serodiagnostic Performance for Lyme Disease by Use of Two Recombinant Proteins in Enzyme-Linked Immunosorbent Assay Compared to Standardized Two-Tier Testing.
    Bradshaw GL; Thueson RK; Uriona TJ
    J Clin Microbiol; 2017 Oct; 55(10):3046-3056. PubMed ID: 28768731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease.
    LaFleur RL; Dant JC; Wasmoen TL; Callister SM; Jobe DA; Lovrich SD; Warner TF; Abdelmagid O; Schell RF
    Clin Vaccine Immunol; 2009 Feb; 16(2):253-9. PubMed ID: 19052162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme-linked immunosorbent assay using recombinant OspC and the internal 14-kDa flagellin fragment for serodiagnosis of early Lyme disease.
    Rauer S; Spohn N; Rasiah C; Neubert U; Vogt A
    J Clin Microbiol; 1998 Apr; 36(4):857-61. PubMed ID: 9542898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid decline of OspC borreliacidal antibodies following treatment of patients with early Lyme disease.
    Jobe DA; Kowalski TJ; Bloemke M; Lovrich SD; Callister SM
    Clin Vaccine Immunol; 2011 Jun; 18(6):1034-7. PubMed ID: 21508161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration of OspC type diversity in invasive human lyme disease isolates and identification of previously uncharacterized epitopes that define the specificity of the OspC murine antibody response.
    Earnhart CG; Buckles EL; Dumler JS; Marconi RT
    Infect Immun; 2005 Dec; 73(12):7869-77. PubMed ID: 16299277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral immune response to outer surface protein C of Borrelia burgdorferi in Lyme disease: role of the immunoglobulin M response in the serodiagnosis of early infection.
    Fung BP; McHugh GL; Leong JM; Steere AC
    Infect Immun; 1994 Aug; 62(8):3213-21. PubMed ID: 8039891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inferring epitopes of a polymorphic antigen amidst broadly cross-reactive antibodies using protein microarrays: a study of OspC proteins of Borrelia burgdorferi.
    Baum E; Randall AZ; Zeller M; Barbour AG
    PLoS One; 2013; 8(6):e67445. PubMed ID: 23826301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Position of His-Tag in Recombinant OspC and Application of Various Adjuvants Affects the Intensity and Quality of Specific Antibody Response after Immunization of Experimental Mice.
    Krupka M; Masek J; Barkocziova L; Turanek Knotigova P; Kulich P; Plockova J; Lukac R; Bartheldyova E; Koudelka S; Chaloupkova R; Sebela M; Zyka D; Droz L; Effenberg R; Ledvina M; Miller AD; Turanek J; Raska M
    PLoS One; 2016; 11(2):e0148497. PubMed ID: 26848589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.